Original language | English (US) |
---|---|
Pages (from-to) | 1935-1944 |
Number of pages | 10 |
Journal | Journal of the American College of Cardiology |
Volume | 61 |
Issue number | 18 |
DOIs | |
State | Published - May 7 2013 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Management of Patients With Atrial Fibrillation (Compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS Recommendations) : A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. / Anderson, Jeffrey L.; Halperin, Jonathan L.; Albert, Nancy M. et al.
In: Journal of the American College of Cardiology, Vol. 61, No. 18, 07.05.2013, p. 1935-1944.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Management of Patients With Atrial Fibrillation (Compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS Recommendations)
T2 - A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
AU - Anderson, Jeffrey L.
AU - Halperin, Jonathan L.
AU - Albert, Nancy M.
AU - Bozkurt, Biykem
AU - Brindis, Ralph G.
AU - Curtis, Lesley H.
AU - DeMets, David
AU - Guyton, Robert A.
AU - Hochman, Judith S.
AU - Kovacs, Richard J.
AU - Ohman, E. Magnus
AU - Pressler, Susan J.
AU - Sellke, Frank W.
AU - Shen, Win Kuang
N1 - Funding Information: Committee Member Research Grant Speakers Bureau Stock Ownership Board of Directors Consultant/Advisory Member David S. Cannom • Guidant • AstraZeneca L.P. • Guidant • Medtronic None None • Cardionet • Cryden DSMB • Guidant Harry J. Crijns • AstraZeneca L.P. • Guidant • Medtronic • Sanofi-aventis None None None • AstraZeneca L.P. • Sanofi-aventis Anne B. Curtis • Medtronic • St. Jude • Guidant • Medtronic • St. Jude Medical None None • Medtronic Kenneth A. Ellenbogen • AstraZeneca • Bristol Myers Squibb/Sanofi Partnership • Guidant • Medtronic • Pfizer • St. Jude Medical None None None • Ablation Frontiers • Biosense Webster • Stereotaxis Valentin Fuster None None None • GlaxoSmithKline • GlaxoSmithKline • Kereos • Vasogen Jonathan L. Halperin None None None None • Astellas Pharama • AstraZeneca • Bayer AG Healthcare • Boehringer Ingelheim • Daiichi Medical Research • GlaxoSmithKline • Sanofi-aventis • Vasogen Jean-Yves Le Heuzey • Sanofi-aventis • Medtronic None None None • 3M • AstraZeneca L.P. • GlaxoSmithKline • Guidant G. Neal Kay None None None None None James E. Lowe None None None None None S. Bertil Olsson • AstraZeneca L.P. None • AstraZeneca L.P. • Upjohn None • AstraZeneca L.P. • Boehringer-Ingelheim Eric N. Prystowsky • Sanofi-aventis • Reliant • CardioNet • CardioNet • Bard • Guidant • Sanofi-aventis • Stereotaxis Lars E. Ryden • AFA Insurance • AstraZeneca • Pfizer • Sanofi-aventis • Swedish Heart Lung Foundation • Occasional lectures at various meetings None • Chair SBU Alert (A governmental Swedish HTA organization evaluating new medical technology • Sanofi-aventis Juan Luis Tamargo None None None None None L. Samuel Wann None None None None None DSMB, Data and Safety Monitoring Board. This table represents the actual or potential relationships with industry that were reported at the initial writing committee meeting on August 27, 2004. This table will be updated in conjunction with all meetings and conference calls of the writing committee.
PY - 2013/5/7
Y1 - 2013/5/7
UR - http://www.scopus.com/inward/record.url?scp=84879298053&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84879298053&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2013.02.001
DO - 10.1016/j.jacc.2013.02.001
M3 - Article
C2 - 23558044
AN - SCOPUS:84879298053
VL - 61
SP - 1935
EP - 1944
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
SN - 0735-1097
IS - 18
ER -